|
|
% |
|
Adoption of
information technology |
47 |
|
Evolution of
employer-provided health insurance |
22 |
|
Increasing
prevalence of chronic medical conditions |
18 |
|
|
|
|
New federal
legislation or regulation |
13 |
|
Increased utilization |
12 |
|
Pharmacogenomics |
12 |
|
Pressures on
pricing for prescription drugs |
10 |
|
The cost of
new technology |
8 |
|
Reimbursement
rates |
8 |
|
Increased competition |
7 |
|
Increasing
rates of patient non-compliance |
6 |
|
A public backlash
against other sectors of the industry |
3 |
|
|
|
|
|
|
|
::
Close Window :: |